David S Boyer

5PUBLICATIONS
15CO-AUTHORS
Geospatial information systems and geospatial data modellingGene and molecular therapyOptical technologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Vision science
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 21, 2026
Efficacy of Continuous Pegcetacoplan Treatment for Subfoveal Geographic Atrophy in Age-Related Macular Degeneration: 36-Month Results from OAKS, DERBY, and GALE Open-Label Extension.

|Mar 02, 2026
Aflibercept 2 mg Biosimilar (aflibercept-ayyh, Pavblu): Experience of safety in clinical settings-APEX- safety study.

Ashish Sharma, Arshad M Khanani, David Eichenbaum

|Aug 16, 2024
Real-World Outcomes of the 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema.

Christine Morozova, Lucas L Humayun, Jonathan Kasper

|Apr 03, 2023
Intravitreal Nesvacumab (Anti-Angiopoietin-2) Plus Aflibercept in Neovascular AMD: Phase 2 ONYX Randomized Trial.

Jeffrey S Heier, Allen C Ho, David S Boyer

|May 11, 2018
Recent advances in understanding and managing retinal vein occlusions.

Daniel D Esmaili, David S Boyer

Pageof 1

Frequent Collaborators

1 joint publications

Ashish Sharma

1 joint publications

Humza Sulahria

1 joint publications

Carl Regillo

1 joint publications

Thomas Schmelter